These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2529858)
1. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Danilewicz JC; Barclay PL; Barnish IT; Brown D; Campbell SF; James K; Samuels GM; Terrett NK; Wythes MJ Biochem Biophys Res Commun; 1989 Oct; 164(1):58-65. PubMed ID: 2529858 [TBL] [Abstract][Full Text] [Related]
2. The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans. Jardine AG; Connell JM; Northridge D; Dilly SG; Cussans NJ; Davidson G; Doyle J; Leckie BL; Lever AF Am J Hypertens; 1990 Sep; 3(9):661-7. PubMed ID: 2145871 [TBL] [Abstract][Full Text] [Related]
3. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats. Scott JM; Barclay PL; Shepperson NB Eur J Pharmacol; 1993 Sep; 242(1):91-7. PubMed ID: 8223941 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodents. Shepperson NB; Barclay PL; Bennett JA; Samuels GM Clin Sci (Lond); 1991 Mar; 80(3):265-9. PubMed ID: 1850687 [TBL] [Abstract][Full Text] [Related]
5. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543 [TBL] [Abstract][Full Text] [Related]